1. A Case of Multiple Arterial Stenoses due to Long-term Nilotinib Exposure
   Satoshi Fujiwara et al, 2021, Japanese Journal of Neurosurgery CrossRef
2. Contribution of intracranial vessel wall magnetic resonance imaging in nilotinib‐associated vascular adverse effects diagnosis
   Diogo Goulart Corrêa et al, 2023, eJHaem CrossRef
3. Tyrosine Kinase Inhibitor-associated Cerebral Arterial Occlusive Disease Treated with High-flow Bypass Surgery: A Case Report
   Yurie RAI et al, 2023, NMC Case Report Journal CrossRef
4. Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events
   Ali Manouchehri et al, 2020, Arteriosclerosis, Thrombosis, and Vascular Biology CrossRef
5. Case report: Three characteristics of tyrosine kinase inhibitor-associated cerebrovascular stenosis. High threshold for infarction, atypical infarct area, and vascular recoverability under the use of ponatinib
   Akira Hanazono et al, 2024, Frontiers in Stroke CrossRef
6. Tyrosine Kinase Inhibitor-induced Cerebrovascular Occlusion Presenting with Moyamoya Disease-like Stenosis of the Circle of Willis
   Takuya Terakawa et al, 2024, Internal Medicine CrossRef